Search
forResearch 10 of 630
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Present Chemotherapy Induced Alopecia and Research in Future
- Index
- Alopecia in patients treated with molecularly targeted anticancer therapies
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma
- Identifying the supportive care needs of men and women affected by chemotherapy-induced alopecia? A systematic review
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →